Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754039 · ClinicalTrials.gov registry record · Phase 4
Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
A Phase 4 study of Hypercholesterolemia and Hyperlipidemia, Familial Combined, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 129
- Enrollment target
- 10
- Study locations
NCT00754039: Completed Phase 4 study of Hypercholesterolemia and Hyperlipidemia, Familial Combined, sponsored by Daiichi Sankyo.
NCT00754039 is a Phase 4 study of Hypercholesterolemia and Hyperlipidemia, Familial Combined that has completed, run by Daiichi Sankyo. The registered enrollment target is 129 participants, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (84% lower). The trial reports 10 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00754039, a Phase 4 study of Hypercholesterolemia and Hyperlipidemia, Familial Combined, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 129 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this study is to compare the effect of Welchol in combination with TriCor compared to TriCor alone on low-density lipoprotein cholesterol (LDL-C) in patients with high cholesterol.
Conditions Studied
Interventions
- DRUG colesevelam HCl tablets and fenofibrate tablets
- DRUG fenofibrate tablets and Welchol placebo tablets
Study Locations (10)
Florida
- - Longwood
- - Ocala
- - Winterpark
Illinois
- - Chicago
- - Lombard
Kansas
- - Overland Park
North Carolina
- - Stateville
Ohio
- - Cincinnati
Texas
- - San Antonio
Virginia
- - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2003-02 |
| Est. Completion | 2004-03 |
| Phase | Phase 4 |
What the finished NCT00754039 record still lists
NCT00754039 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which colesevelam HCl tablets and fenofibrate tablets is the first listed.
NCT00754039 lists 10 locations in 7 states (Florida, Illinois, Kansas).
Frequently Asked Questions
What is clinical trial NCT00754039 about?
NCT00754039 is a clinical study titled "Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol". The primary objective of this study is to compare the effect of Welchol in combination with TriCor compared to TriCor alone on low-density lipoprotein cholesterol (LDL-C) in patients with high cholesterol.
What is the current status of trial NCT00754039?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 129 participants. The study started on 2003-02. Estimated completion is 2004-03.
What conditions does trial NCT00754039 study?
This clinical trial studies the following conditions: Hypercholesterolemia, Hyperlipidemia, Familial Combined.
What interventions are being tested in trial NCT00754039?
The interventions under investigation include: colesevelam HCl tablets and fenofibrate tablets (DRUG), fenofibrate tablets and Welchol placebo tablets (DRUG).
Who is sponsoring clinical trial NCT00754039?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00754039 being conducted?
This trial has 10 study locations across Florida, Illinois, Kansas, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00754039's enrollment target sits among peer trials
129 36th of 62 higher than 27 of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
COMPLETED · Phase 4
-
Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
COMPLETED · Phase 4
-
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
COMPLETED · Phase 4
-
Cholesterol and Pharmacogenetic Study
COMPLETED · Phase 4
-
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
COMPLETED · Phase 4
-
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia